Combined antiplatelet and anticoagulant therapy for patients with mitral stenosis
Claire Braybrook
This article has no abstract so we have provided the first paragraph of the full text.
No consensus exists regarding the appropriate intensity of anticoagulation therapy in patients with mitral stenosis associated with atrial fibrillation (AF). In the National Study for Prevention of Embolism in Atrial Fibrillation (NASPEAF), the effects of antithrombotic therapy were assessed in a high-risk group containing patients with mitral stenosis and patients with nonvalvular AF plus embolism. Pérez-Gómez et al. have followed this study with an independent evaluation of antithrombotic therapy in these two subgroups.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
